Psychedelic Titans Updates for the Psychedelics Industry

Psychedelics News

Psychedelic Titans

Breaking News, Press Releases, Psychedelic Groundbreakers, Psychedelic Titans, Science

28 Aug 2025

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

AbbVie’s quiet acquisition of Gilgamesh Pharmaceuticals, reportedly worth close to $1 billion, did more than make headlines. It signaled something far more significant: Big Pharma has officially entered the psychedelic-adjacent...

By Madison Roberts

Breaking News, Health & Wellness, Industry, Psychedelic Groundbreakers, Psychedelic Titans, Science

18 Aug 2025

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

But while traditional psychedelic developers dominate headlines, Enveric Biosciences (NASDAQ: ENVB) has stayed quietly in the background, focusing on an equally groundbreaking, but less flashy, approach: non-hallucinogenic neuroplastogens, small molecules...

By Madison Roberts

Breaking News, Health & Wellness, Industry, Press Releases, Psychedelic Groundbreakers, Psychedelic Titans, Science

15 Jul 2025

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

Enveric Biosciences announced that its lead compound, EB-003, significantly reduced trauma-related fear behaviors in a preclinical PTSD model—highlighting its potential as a fast-acting, non-hallucinogenic treatment for a condition with few...

By Madison Roberts

Industry, Psychedelic Titans, Science

31 Mar 2025

The Future of Psychedelics: Why Next-Generation Molecules Will Win

The psychedelic industry is undergoing a major transformation. With new, non-hallucinogenic compounds on the rise, companies like Enveric Biosciences, Delix Therapeutics, and Gilgamesh Pharmaceuticals are leading the way in developing...

By Madison Roberts

Join Our Newsletter for Exclusive Updates, Stories, and More

Psychedelic Titans

12 May 2022

Psychedelic Titans with Allison Feduccia of Psychedelic Support

Psychedelic Support is the leading online education and therapeutic platform in the psychedelic space advocating for mental health and wellbeing worldwide....

By Microdose

Psychedelic Titans

24 Mar 2022

Psychedelic Titans with Cory Jones of Healing Maps

This week's Psychedelic Titan is Cory Jones, CEO for Healing Maps....

By Microdose

Psychedelic Titans

11 Feb 2022

Psychedelic Titans with Edward Pearson of KetaMD.com

Psychedelic Titan Edward Pearson is Medical Director of KetaMD....

By Microdose

Psychedelic Titans

3 Feb 2022

Psychedelic Titans with Nathaniel Morris of PeyoteLab.com

This week's Psychedelic Titan is Nathaniel Morris, Peyote horticulturist and researcher for PeyoteLab....

By Microdose

Psychedelic Titans

27 Jan 2022

Psychedelic Titans with Del Potter of Alvarius Pharmaceuticals

Psychedelic Titan Del Potter is Chief Scientific Officer of Alvarius Pharmaceuticals....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result